MCID: AGN002
MIFTS: 56

Agnosia

Categories: Eye diseases, Mental diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Agnosia

MalaCards integrated aliases for Agnosia:

Name: Agnosia 12 53 54 29 44 15 73
Primary Visual Agnosia 53 73
Dyspraxia 12 54
Apraxias 44 73
Monomodal Visual Amnesia 53
Dyspraxia Syndrome 12
Visual Amnesia 53
Alexia 73

Classifications:



External Ids:

Disease Ontology 12 DOID:4090
ICD10 33 R48.1 R48.2
NCIt 50 C84542

Summaries for Agnosia

NIH Rare Diseases : 53 Agnosia is characterized by an inability to recognize and identify objects and/or persons. Symptoms may vary, according to the area of the brain that is affected. It can be limited to one sensory modality such as vision or hearing; for example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. Agnosia can result from strokes, traumatic brain injury, dementia, a tumor, developmental disorders, overexposure to environmental toxins (e.g., carbon monoxide poisoning), or other neurological conditions. Visual agnosia may also occur in association with other underlying disorders. People with agnosia may retain their cognitive abilities in other areas. Treatment of primary agnosia is symptomatic and supportive; when it is caused by an underlying disorder, treatment of the disorder may reduce symptoms and help prevent further brain damage.

MalaCards based summary : Agnosia, also known as primary visual agnosia, is related to pain agnosia and withdrawal disorder, and has symptoms including seizures, fever and dyspnea. An important gene associated with Agnosia is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1), and among its related pathways/superpathways are Signaling by GPCR and Peptide ligand-binding receptors. The drugs Flurbiprofen and Dezocine have been mentioned in the context of this disorder. Affiliated tissues include brain, parietal lobe and eye, and related phenotypes are behavior/neurological and adipose tissue

Disease Ontology : 12 A communication disorder that is a loss of ability to recognize objects, persons, sounds, shapes, or smells while the specific sense is not defective nor is there any significant memory loss.

NINDS : 54 Agnosia is a rare disorder characterized by an inability to recognize and identify objects or persons. People with agnosia may have difficulty recognizing the geometric features of an object or face or may be able to perceive the geometric features but not know what the object is used for or whether a face is familiar or not. Agnosia can be limited to one sensory modality such as vision or hearing. For example, a person may have difficulty in recognizing an object as a cup or identifying a sound as a cough. Agnosia can result from strokes, dementia, developmental disorders, or other neurological conditions. It typically results from damage to specific brain areas in the occipital or parietal lobes of the brain. People with agnosia may retain their cognitive abilities in other areas.

Wikipedia : 76 Agnosia is the inability to process sensory information. Often there is a loss of ability to recognize... more...

Related Diseases for Agnosia

Diseases in the Agnosia family:

Form Agnosia

Diseases related to Agnosia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 288)
# Related Disease Score Top Affiliating Genes
1 pain agnosia 31.4 AP1M2 AP2M1 CCK CNR1 HTR7 IER3IP1
2 withdrawal disorder 29.8 CNR1 HTR7 OPRM1 PDYN POMC
3 ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 12.6
4 ocular motor apraxia 12.6
5 visual agnosia 12.5
6 auditory agnosia 12.5
7 apperceptive agnosia 12.5
8 ataxia-oculomotor apraxia 4 12.5
9 rolandic epilepsy, mental retardation, and speech dyspraxia, x-linked 12.4
10 tactile agnosia 12.4
11 verbal auditory agnosia 12.4
12 finger agnosia 12.4
13 developmental dyspraxia 12.4
14 ataxia-oculomotor apraxia 3 12.4
15 integrative agnosia 12.4
16 form agnosia 12.4
17 topographical agnosia 12.4
18 social emotional agnosia 12.3
19 associative agnosia 12.3
20 mirror agnosia 12.3
21 visual verbal agnosia 12.3
22 semantic agnosia 12.3
23 gait apraxia 12.2
24 time agnosia 12.2
25 color agnosia 12.2
26 apraxia of eyelid opening 12.1
27 primary progressive apraxia of speech 12.1
28 spinocerebellar ataxia, autosomal recessive 1 12.1
29 rolandic epilepsy-speech dyspraxia syndrome 12.0
30 astereognosia 12.0
31 autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome 12.0
32 x-linked intellectual disability-ataxia-apraxia syndrome 12.0
33 spinocerebellar ataxia with axonal neuropathy type 2 11.8
34 epilepsy, focal, with speech disorder and with or without mental retardation 11.8
35 pilarowski-bjornsson syndrome 11.7
36 childhood apraxia of speech 11.7
37 autotopagnosia 11.6
38 developmental coordination disorder 11.5
39 poretti-boltshauser syndrome 11.5
40 birk-landau-perez syndrome 11.5
41 cortical deafness 11.5
42 gerstmann syndrome 11.5
43 prosopagnosia 11.5
44 galactosemia 11.4
45 ataxia-telangiectasia 11.3
46 apraxia 11.3
47 alexia 11.3
48 wieacker-wolff syndrome 11.3
49 phonagnosia 11.3
50 alexithymia 11.3

Graphical network of the top 20 diseases related to Agnosia:



Diseases related to Agnosia

Symptoms & Phenotypes for Agnosia

UMLS symptoms related to Agnosia:


seizures, fever, dyspnea, edema, cachexia, vertigo, clumsiness, abnormality of extrapyramidal motor function, headache, torticollis, syncope, scanning speech, cyanosis, visual agnosia, muscle rigidity, icterus, signs and symptoms, signs and symptoms, digestive, other symbolic dysfunction, hot flushes, symptoms

MGI Mouse Phenotypes related to Agnosia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.7 CCK CNR1 HTR7 OPRL1 OPRM1 OXT
2 adipose tissue MP:0005375 9.63 CNR1 OPRM1 OXT PDYN POMC TRPV1
3 integument MP:0010771 9.32 CNR1 HTR7 OPRL1 OPRM1 OXT PDYN

Drugs & Therapeutics for Agnosia

Drugs for Agnosia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 113)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Flurbiprofen Approved, Investigational Phase 4 5104-49-4 3394
2
Dezocine Approved, Investigational Phase 4 53648-55-8 3033053 40841
3
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
4
Nalbuphine Approved Phase 4 20594-83-6 5311304 5360630
5
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
6
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 57-27-2 5288826
7
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Not Applicable 1177-87-3
8
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
9
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Not Applicable 50-02-2 5743
10
Levobupivacaine Approved, Investigational Phase 4,Not Applicable 27262-47-1 92253
11
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
12
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 137-58-6 3676
13
Ropivacaine Approved Phase 4,Phase 3,Not Applicable 84057-95-4 175805 71273
14
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
15
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
16
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
17
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
18
Ibuprofen Approved Phase 4,Not Applicable 15687-27-1 3672
19
Clonidine Approved Phase 4 4205-90-7 2803
20
Tramadol Approved, Investigational Phase 4,Phase 3 27203-92-5 33741
21
Sufentanil Approved, Investigational Phase 4,Not Applicable 56030-54-7 41693
22
Remifentanil Approved Phase 4,Phase 3,Not Applicable 132875-61-7 60815
23
Ketoprofen Approved, Vet_approved Phase 4 22071-15-4 3825
24 Nefopam Approved, Investigational Phase 4 13669-70-0
25
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3 2078-54-8 4943
26 Cyclooxygenase Inhibitors Phase 4,Not Applicable
27 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Not Applicable
28 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 3,Not Applicable
29 Adrenergic Agents Phase 4,Not Applicable
30 Adrenergic alpha-2 Receptor Agonists Phase 4,Not Applicable
31 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
32 Hypnotics and Sedatives Phase 4,Phase 3,Not Applicable
33 Adrenergic alpha-Agonists Phase 4,Not Applicable
34 Narcotics Phase 4,Phase 2,Phase 3,Not Applicable
35 Antirheumatic Agents Phase 4,Not Applicable
36 Adrenergic Agonists Phase 4,Not Applicable
37 Analgesics Phase 4,Phase 2,Phase 3,Not Applicable
38 Analgesics, Opioid Phase 4,Phase 2,Phase 3,Not Applicable
39 Neurotransmitter Agents Phase 4,Not Applicable
40 Anti-Inflammatory Agents Phase 4,Not Applicable
41 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
42 Anesthetics, Dissociative Phase 4
43 Anesthetics, General Phase 4,Phase 3,Not Applicable
44 Excitatory Amino Acid Antagonists Phase 4,Not Applicable
45 Excitatory Amino Acids Phase 4,Not Applicable
46 Anesthetics Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
47 Anesthetics, Intravenous Phase 4,Phase 3,Not Applicable
48 Anesthetics, Local Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
49 BB 1101 Phase 4,Not Applicable
50 Antipyretics Phase 4,Phase 2,Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 69)
# Name Status NCT ID Phase Drugs
1 Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia Unknown status NCT03014713 Phase 4 Dezocine;Flubiprofen;Dexmedetomidine
2 Ketamine and Postoperative Analgesia in Children Unknown status NCT00200564 Phase 4 ketamine
3 Effects of Catheter Location on Postoperative Analgesia for Continuous Adductor Canal and Popliteal-Sciatic Nerve Blocks Completed NCT02523235 Phase 4 ropivacaine 0.2%
4 The Combination Effect of Dexmedetomidine and Morphine in Postoperative Patient-Controlled Analgesia Completed NCT00800826 Phase 4 dexmedetomidine
5 Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia Completed NCT02516059 Phase 4 oxycodone/naloxone;Oxycodone;Placebo
6 Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery Completed NCT01966172 Phase 4 Ibuprofen;Gabapentin;Morphine;Paracetamol
7 Postoperative Pain and SIRS After Preoperative Analgesia With Clonidine or Levobupivacaine Completed NCT00860899 Phase 4 clonidine, levobupivacaine
8 Continuous Infusion of Dexamethasone Plus Tramadol Adjunct to Morphine PCA After Abdominal Hysterectomy Completed NCT00564603 Phase 4 Dexamethasone Sodium Phosphate Injection
9 Intravenous and Intraperitoneal Lignocaine for Perioperative Analgesia in Laparoscopic Colon Resections Recruiting NCT03105193 Phase 4 IV Saline bolus and infusion;IP Saline bolus and infusion;IV lignocaine bolus and infusion;IP Lignocaine bolus and infusion
10 Dexmedetomidine Supplemented Analgesia and 2-Year Survival After Cancer Surgery Recruiting NCT03012971 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
11 Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery. Recruiting NCT03007121 Phase 4 Morphine intrathecal;Bupivacaine + Sufentanil epidural;Morphine intravenous
12 Dexmedetomidine Supplemented Intravenous Analgesia in Elderly After Orthopedic Surgery Recruiting NCT03629262 Phase 4 Dexmedetomidine;Placebo
13 Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium Recruiting NCT03012984 Phase 4 Dexmedetomidine supplemented morphine analgesia;Morphine analgesia
14 Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. Terminated NCT01882530 Phase 4 Paracetamol;Nefopam;Ketoprofen;Morphine
15 A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation. Terminated NCT00421720 Phase 4 Sufentanil;Remifentanil
16 A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-based Postoperative Analgesia Unknown status NCT02811991 Phase 2, Phase 3 Paracetamol injection;Normal Saline injection;Morhpine PCA
17 Combination Analgesia for Neonatal Circumcision Completed NCT02990364 Phase 3 Sucrose;Lidocaine;EMLA Topical Product
18 Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia Completed NCT02264821 Phase 3 ropivacaine infiltration;intrathecal morphine;placebo
19 Tramadol Versus Fentanyl for Post-Operative Analgesia in Newborn Infants Completed NCT00713726 Phase 3 FentanyL;Tramadol
20 Continuous Regional Analgesia After Total Knee Arthroplasty Completed NCT00337597 Phase 3
21 Pharmacoeconomic Consequences Of Analgesia in the Intensive Care Unit (ICU) Terminated NCT00436345 Phase 3 Remifentanil;Propofol
22 Development of a New Method for Analgesia Completed NCT00791024 Phase 1, Phase 2 CRC-Pharma 001;lidocaine suspension
23 Dexamethasone Added to Levobupivacaine Improves Postoperative Analgesia Unknown status NCT01739270 Not Applicable
24 Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients Unknown status NCT01553435 Not Applicable Dextromethorphan;Placebo
25 Do Epidurals Placed at a Lower Level Improve Labor Analgesia? Unknown status NCT00954317 Not Applicable
26 Depodur vs Fentanyl Infusion for Post-C/S Analgesia Unknown status NCT00762554 Not Applicable Depodur;Depodur;Fentanyl
27 Low Level Laser (LED) Use to Increase Dental Implant Stability and Post Operative Analgesia Unknown status NCT01097499 Not Applicable
28 Effect of Thoracic Epidural Analgesia for Thoracotomy on the Occurrence of AF Unknown status NCT01718717 Not Applicable
29 Dietary Supplement for the Prevention of Cognitive Decline in a Very Elderly Population. Unknown status NCT01817101 Not Applicable
30 Perception and Multisensory Integration in Neurological Patients Using fMRI Unknown status NCT01469858 Not Applicable
31 Orientation Agnosia: Clinical and Anatomical Study Completed NCT01304576 Not Applicable
32 Newborn Cortical Response to Pain and Non Pharmacological Analgesia Completed NCT03389789 Not Applicable
33 Comparison of Patient-Controlled Analgesia With Different Background Infusion Completed NCT03221491 Not Applicable
34 Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT03203967 Not Applicable Intravenous morphine analgesia
35 Individualized Analgesia on Respiratory Adverse Events After Adenotonsillectomy Completed NCT02990910 Not Applicable personalized opioid analgesia
36 A Randomised Controlled Trial Comparing Single Shot Adductor Canal Block With Local Infiltration Analgesia for Postoperative Analgesia After Total Knee Arthroplasty Completed NCT02104934 Not Applicable
37 μ-opioid Receptor Polymorphism and Opioid Analgesia Completed NCT02099877 Fentanyl
38 The Effect of Oxytocin on Placebo Analgesia: an Experimental Study in Healthy Volunteers Completed NCT01886014 Not Applicable Oxytocin
39 Labour Analgesia and Movement in Babies Completed NCT01280084
40 The Randomised Epidural Analgesia in Term Delivering Women Trial (TREAT) Completed NCT01261689 Not Applicable Ropivacaine/ Sufentanil according to local hospital protocol
41 Effect of Timing on Efficacy of Morphine Analgesia After 2-chloroprocaine Anesthesia Completed NCT00487084 Not Applicable Morphine-CP-saline (MCS);saline-2CP-morphine (SCM);saline-lidocaine-morphine (SLM)
42 Combined Implementation of Dural Puncture Epidural and Programmed Intermittent Epidural Bolus for Labor Analgesia Completed NCT03366935 Not Applicable
43 Individualized Timing of Analgesia and Effectiveness of Labor Analgesia Completed NCT02920489 Not Applicable Individualized epidural analgesia;Routine epidural analgesia
44 Epidural Analgesia in Intensive Care Unit (APD-REA: Analgesie PeriDurale en REAnimation) Completed NCT01437358
45 Effects of Thoracic Epidural Analgesia and Surgery on Lower Urinary Tract Function: A Randomized, Controlled Study Completed NCT01220362 Not Applicable Bupivacain 0.125%;Bupivacain 0.125%/Fentanyl 2mcg/ml
46 Surgical Stress Index as a Tool for Monitoring Analgesia and/or Sedation in Critically Ill Patients Completed NCT00789412
47 Telemedically Supported Analgesia in the Emergency Medical Service Completed NCT01644032 Not Applicable
48 Monitor-Guided Analgesia During General Anesthesia - Part I Completed NCT03303651 Not Applicable
49 Functional Magnetic Resonance Imaging (fMRI) of Anosognosia in Amnestic Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) Completed NCT00908999
50 Neuraxial Labor Analgesia and the Incidence of Postpartum Depression Completed NCT02823418

Search NIH Clinical Center for Agnosia

Cochrane evidence based reviews: agnosia

Genetic Tests for Agnosia

Genetic tests related to Agnosia:

# Genetic test Affiliating Genes
1 Agnosia 29

Anatomical Context for Agnosia

MalaCards organs/tissues related to Agnosia:

41
Brain, Parietal Lobe, Eye, Cortex, Temporal Lobe, Testes, Spinal Cord

Publications for Agnosia

Articles related to Agnosia:

(show top 50) (show all 439)
# Title Authors Year
1
Visual texture agnosia in dementia with Lewy bodies and Alzheimer's disease. ( 29673784 )
2018
2
Agnosia Interferes With Daily Hygiene in Patients With Dementia. ( 29900188 )
2018
3
Agnosia for bird calls. ( 29572063 )
2018
4
Agnosia ( 29630208 )
2018
5
Association vs dissociation and setting appropriate criteria for object agnosia. ( 29658418 )
2018
6
Perceptual deficits of object identification: apperceptive agnosia. ( 29519462 )
2018
7
The neuropsychological rehabilitation of visual agnosia and Balint's syndrome. ( 29366371 )
2018
8
Apraxia, Neglect, and Agnosia. ( 29851877 )
2018
9
The contribution of facial dynamics to subtle expression recognition in typical viewers and developmental visual agnosia. ( 29723598 )
2018
10
Verbal auditory agnosia in a patient with traumatic brain injury: A case report. ( 29538212 )
2018
11
Should developmental prosopagnosia, developmental body agnosia, and developmental object agnosia be considered independent neurodevelopmental conditions? ( 29658410 )
2018
12
Supramodal agnosia for oblique mirror orientation in patients with periventricular leukomalacia. ( 29655042 )
2018
13
Neuromodulation of Right Auditory Cortex Selectively Increases Activation in Speech-Related Brain Areas in Brainstem Auditory Agnosia. ( 30239465 )
2018
14
The painter from Sinaloa: artistic analysis of a case of spatial agnosia and neglect of visual shapes. ( 29185377 )
2017
15
Relationship between somatosensory event-related potential N140 aberrations and hemispatial agnosia in patients with stroke: a preliminary study. ( 29076767 )
2017
16
Impaired peripheral reaching and on-line corrections in patient DF: Optic ataxia with visual form agnosia. ( 28532578 )
2017
17
Landmark Agnosia: Evaluating the Definition of Landmark-based Navigation Impairment. ( 28164221 )
2017
18
Auditory agnosia caused by bilateral putamen haemorrhage. ( 29269367 )
2017
19
Pure Amorphagnosia without Tactile Object Agnosia. ( 28559827 )
2017
20
Evidence of taxonomy for Developmental Topographical Disorientation: Developmental Landmark Agnosia Case 1. ( 29192795 )
2017
21
Stroke of the inferiomedial temporal lobe causing word agnosia. ( 28747411 )
2017
22
Visual agnosia and focal brain injury. ( 28843416 )
2017
23
Congenital prosopagnosia without object agnosia? A literature review. ( 29165034 )
2017
24
Preserved Expert Object Recognition in a Case of Unilateral Visual Agnosia. ( 28949822 )
2017
25
Poster 215 Gustatory Agnosia Following Herpes Simplex Virus Encephalitis: A Case Report. ( 27672976 )
2016
26
Impaired Velocity Processing Reveals an Agnosia for Motion in Depth. ( 27677897 )
2016
27
Enhancing Diversity in Academic Neurology: From Agnosia to Action. ( 26972163 )
2016
28
Pearls & Oy-sters: Visual agnosia: An overlooked cortical sign. ( 27821572 )
2016
29
Hurt but still alive: Residual activity in the parahippocampal cortex conditions the recognition of familiar places in a patient with topographic agnosia. ( 26909331 )
2016
30
Functional dissociation between action and perception of object shape in developmental visual object agnosia. ( 26827163 )
2016
31
Agnosia for head tremor in essential tremor: prevalence and clinical correlates. ( 26877883 )
2016
32
What's in the name 'alexithymia'? A commentary on "Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy.". ( 27235080 )
2016
33
Emotional quotient in frontotemporal dementia vs. Alzheimer's disease: the role of socioemotional agnosia. ( 27903133 )
2016
34
Pure word deafness with auditory object agnosia after bilateral lesion of the superior temporal sulcus. ( 26343343 )
2015
35
Emergence delirium with transient associative agnosia and expressive aphasia reversed by flumazenil in a pediatric patient. ( 26035220 )
2015
36
Intact implicit representation of object 3D structure in object agnosia. ( 26326787 )
2015
37
Tactile Toe Agnosia and Percept of a "Missing Toe" in Healthy Humans. ( 26562866 )
2015
38
Functional Mapping of the Human Auditory Cortex: fMRI Investigation of a Patient with Auditory Agnosia from Trauma to the Inferior Colliculus. ( 26413744 )
2015
39
Real-time vision, tactile cues, and visual form agnosia: removing haptic feedback from a "natural" grasping task induces pantomime-like grasps. ( 25999834 )
2015
40
Auditory agnosia. ( 25726291 )
2015
41
Reprint of: Visual processing of words in a patient with visual form agnosia: A behavioural and fMRI study. ( 26475097 )
2015
42
Visual agnosia. ( 26358494 )
2015
43
Visual processing of words in a patient with visual form agnosia: a behavioural and fMRI study. ( 25461705 )
2015
44
Affective agnosia: Expansion of the alexithymia construct and a new opportunity to integrate and extend Freud's legacy. ( 26054794 )
2015
45
Which visual functions depend on intermediate visual regions? Insights from a case of developmental visual form agnosia. ( 26209358 )
2015
46
Simultanagnosia and scene agnosia induced by right posterior cerebral artery infarction: a case report. ( 26369377 )
2015
47
Auditory agnosia as a clinical symptom of childhood adrenoleukodystrophy. ( 25544384 )
2015
48
Psychosis, agnosia, and confabulation: an alternative two-factor account. ( 24328860 )
2014
49
Neurodegeneration and mirror image agnosia. ( 25317393 )
2014
50
Pure associative tactile agnosia for the left hand: clinical and anatomo-functional correlations. ( 25046697 )
2014

Variations for Agnosia

Expression for Agnosia

Search GEO for disease gene expression data for Agnosia.

Pathways for Agnosia

GO Terms for Agnosia

Cellular components related to Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 perikaryon GO:0043204 9.5 CCK NPFF OPRM1
2 neuronal cell body GO:0043025 9.35 CCK PDYN PNOC TAC1 TRPV1
3 axon terminus GO:0043679 9.33 NPFF PDYN PNOC
4 clathrin adaptor complex GO:0030131 9.26 AP1M2 AP2M1
5 dendrite GO:0030425 9.17 CCK HTR7 NPFF OPRM1 PDYN PNOC

Biological processes related to Agnosia according to GeneCards Suite gene sharing:

(show all 30)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.93 CCK NPFF OXT PDYN PNOC POMC
2 G protein-coupled receptor signaling pathway GO:0007186 9.9 CCK CNR1 HTR7 NPFF OPRL1 OPRM1
3 chemical synaptic transmission GO:0007268 9.89 HTR7 NPFF PDYN PNOC TAC1
4 positive regulation of cytosolic calcium ion concentration GO:0007204 9.84 NPFF OXT TAC1 TRPV1
5 memory GO:0007613 9.78 CCK CNR1 OXT
6 excitatory postsynaptic potential GO:0060079 9.76 NPFF OPRM1 TRPV1
7 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger GO:0007187 9.74 CNR1 HTR7 OPRM1
8 response to cocaine GO:0042220 9.7 CNR1 OPRM1 OXT
9 negative regulation of blood pressure GO:0045776 9.69 CNR1 OPRL1 OXT
10 response to morphine GO:0043278 9.67 CNR1 NPFF OPRM1 TAC1
11 maternal process involved in female pregnancy GO:0060135 9.65 CNR1 NPFF
12 sensory perception of pain GO:0019233 9.65 CNR1 OPRL1 OPRM1 TAC1 TRPV1
13 response to food GO:0032094 9.64 OPRM1 OXT
14 response to pain GO:0048265 9.64 TAC1 TRPV1
15 estrous cycle GO:0044849 9.63 OPRL1 OPRM1
16 positive regulation of ossification GO:0045778 9.63 OXT TAC1
17 positive regulation of renal sodium excretion GO:0035815 9.62 OXT TAC1
18 eating behavior GO:0042755 9.62 CCK OPRL1 OPRM1 OXT
19 negative regulation of heart rate GO:0010459 9.61 NPFF TAC1
20 positive regulation of blood pressure GO:0045777 9.61 CNR1 NPFF OXT
21 negative regulation of appetite GO:0032099 9.6 CCK NPFF
22 opioid receptor signaling pathway GO:0038003 9.59 OPRL1 OPRM1
23 acute inflammatory response to antigenic stimulus GO:0002438 9.58 NPFF OPRM1
24 sensory perception GO:0007600 9.58 OPRL1 OPRM1 PNOC
25 positive regulation of sensory perception of pain GO:1904058 9.56 CCK OPRL1
26 negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0106072 9.55 OPRL1 OPRM1
27 positive regulation of gastric acid secretion GO:0060454 9.48 OPRL1 TRPV1
28 regulation of sensory perception of pain GO:0051930 9.35 CCK NPFF OPRL1 OPRM1 OXT
29 neuropeptide signaling pathway GO:0007218 9.17 NPFF OPRL1 OPRM1 PDYN PNOC POMC
30 signal transduction GO:0007165 10.22 CCK CNR1 HTR7 OPRL1 OPRM1 OXT

Molecular functions related to Agnosia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 9.43 CCK OXT POMC
2 neuropeptide binding GO:0042923 9.32 OPRL1 OPRM1
3 opioid receptor activity GO:0004985 9.16 OPRL1 OPRM1
4 opioid peptide activity GO:0001515 8.96 PDYN PNOC
5 neuropeptide hormone activity GO:0005184 8.92 CCK NPFF OXT PNOC

Sources for Agnosia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....